Archives: Agenda

• Cultivating collaborative team dynamics
• Emphasizing the value of diverse thinking for problem-solving and creative solutions
• Implementing ongoing training programs to upskill team members and address skill gaps
• Providing mentorship and coaching opportunities to nurture individual growth

• New technologies for rapid and accurate quantification of tissue stem cells used for stem cell and gene therapy clinical trials
• New capabilities for certifying cells supplied for stem cell therapy and gene therapy clinical trials
• Future regulatory impact of emerging methods for certifying the specific dosage stem cells in cell therapy products

• Role of clinical supply chain in within the organization
• Scalability and building an effective internal/external supply chain team
• Strategies for outsourcing supply chain functions
• Developing, maintaining, and implementing consistent and streamlined SOPs, business processes and infrastructure to improve departments effectiveness

Site team responsibilities need to be less time and effort consuming.

PIs need to be more engaged and involved.

The patient’s HCP needs to be integrated.

Site/CRO/Sponsor communication needs to be improved.

“Underrepresented” patients need to be enrolled

• Evolution of clinical trials and need for decentralization
• Regulatory compliance in decentralized clinical trials (DCT)
• Qualification, oversight, and accountability of DCT vendors
• Assurance of quality and consistency of critical study activities performed remotely
• Maintaining control, accountability and subject privacy when delivering IP remotely
• Managing challenges with subject engagement and study compliance
• Ensuring control when things are out of your direct control

• Exposing the inefficiencies of current vendor qualification practices and challenging the industry to adopt a proven process innovation that will help Sponsors onboard Providers more quickly leading to a real reduction in clinical trial start-up times.
• Learn how embracing innovation, and adopting a risk-based data-driven approach to vendor management can help organizations become inspection ready in a heavily regulated industry.
• Uncover the benefits of a centralized approach to vendor qualification that provides unique benefits to both Sponsors and Providers across the globe.

• How does a fully digitised ecosystem improve processes within the transfer of money?
• Discuss the steps to take towards digitising the automation of payments
• Mitigate risk, and take steps into the future of payments

• Review key insights into geopolitics and AI from an insurance perspective 
• Discuss challenges such as geopolitical risks, AI complexity, climate uncertainty, supply chain tension, and cybersecurity obstacles 
• How the Insurance industry can stay ahead of the oncoming challenges of geopolitics and AI 

• Discuss opportunities and challenges to the use and implementation of AI across the sector 
• Find answers to the questions: Do you see AI as something that is working or not? Do you see AI as a threat or an opportunity?